Company Search:
Advanced Search
Sponsored Links
D Pharm Limited Company Snapshot
D Pharm Limited operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares D Pharm Limited with three other pharmaceutical manufacturers in Middle East: Solegreen Ltd (2013 sales of 3.77 million Israel Shekels [US$977,447.90 ] ), Rosetta Genomics Ltd. (USA) (1.46 million Israel Shekels [US$378,108.06 ] ), and BioLight Life Sciences Ltd (82,000.00 Israel Shekels [US$21,260.14 ] ).

Sales Analysis.
  Stock Performance Chart for D Pharm Limited
  Stock Data: Recent Stock Performance:
  Current Price (10/20/2016): 1.16
(Figures in Israel Shekels)
1 Week 3.7%   13 Weeks 0.2%  
4 Weeks -43.8%   52 Weeks 1,169.2%  
D Pharm Limited Key Data:
  Ticker: DPRM Country: Israel
  Exchanges: TEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2013 Sales 995,000
(Year Ending Jan 2014).
Employees: 12
  Currency: Israel Shekels Market Cap: 5,342,668
  Fiscal Yr Ends: December Shares Outstanding: 4,625,687
  Share Type: Ordinary Closely Held Shares: 2,943,373
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.